Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways

Thyroid cancer is the fifth most common cancer diagnosed in women worldwide. Notwithstanding advancements in the prognosis and treatment of thyroid cancer, 10–20% of thyroid cancer patients develops chemotherapeutic resistance and experience relapse. According to previous reports and TCGA database,...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Cheolwon, Thi Thao Tran, Nguyen, Van Ngu, Trinh, Park, Sae Woong, Song, Min Suk, Kim, Sung Hyun, Bae, Yun-Ui, Ayudthaya, Penchatr Diskul Na, Munir, Javaria, Kim, Eunbit, Baek, Moo-Jun, Song, Sujung, Ryu, Seongho, Nam, Kee-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232104/
https://www.ncbi.nlm.nih.gov/pubmed/30420637
http://dx.doi.org/10.1038/s41389-018-0094-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232104/
https://www.ncbi.nlm.nih.gov/pubmed/30420637
http://dx.doi.org/10.1038/s41389-018-0094-y

Ejemplares similares